Chemoradiotherapy in Elderly Patients With Oesophagus Cancer

Management of elderly patient with cancer is a therapeutic challenge and a public health problem. The mean age of esophageal cancer is 64.5 years and 72.1 years in men and women respectively. Surgery is a standard treatment reserved to about 30 % of patients. The other 70 % are considered unfit for surgery for various reasons, including ageing. Chemoradiotherapy (CRT) is standard treatment for patients with esophageal cancer unfit for surgery. The validated treatment scheme is external beam radiotherapy (EBRT) 50 Gy over 5 weeks combined with cisplatin and 5FU infusion. However it induces hig

Trial Details

NCT ID
NCT02735057
Phase
PHASE1 / PHASE2
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
RECRUITING
Cancer Type
Esophageal Cancer
Interventions
  • Carboplatin
Locations (sample)
  • Besançon, France|47.24878,6.01815

Key Eligibility Criteria

  • Esophageal cancer, squamous and adenocarcinoma types, T1-3, N0-1, M1a (TNM 6th),
  • age \> 75 years,
  • WHO status \< 2, Balducci 1, adequate bone marrow reserve, normal renal and hepatic function.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Esophageal Cancer Trials on Trialify →